GGrantIndex
Sort

48,018 grants matching immunotherapy

ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES

$717,641
Massimo T Pietropaolo · Baylor College Of Medicine · R01 · FY2019 · DK

Single domain antibodies for diagnosis and treatment of synucleinopathies

$717,491
Einar M Sigurdsson · New York University School Of Medicine · R56 · FY2023 · AG

Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma

$717,369
Mark Yarchoan · Johns Hopkins University · R01 · FY2025 · CA

Personalized Adoptive T-cell Therapy for AML

$717,103
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA

Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients

$716,939
Angus W Thomson · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AI

Enhancing B7-H3-CAR T cell therapy for pediatric solid tumors

$716,793
Christopher C. Derenzo · St. Jude Children'S Research Hospital · R01 · FY2024 · CA

Cancer Stem Cells in Cholangiocarcinoma

$716,564
Changqing Xie · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

DLL3-targeted IL18-secreting CAR T cells in Small Cell Lung Cancer

$716,521
Adam J Schoenfeld · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention

$716,410
Sophia S. Wang · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA

Modulating pathogenic T cells in Type 1 diabetes

$716,366
Kevan C Herold · Yale University · R01 · FY2025 · DK

CATALYTIC HIV ANTIBODIES

$716,342
University Of Texas Hlth Sci Ctr Houston · P01 · FY2001 · AI

Neural response to inflammatory challenge in major depressive disorder

$716,247
Jonathan Savitz · Laureate Institute For Brain Research · R01 · FY2024 · MH

Dynamics, Regulation and Function of p53 in Single Cells

$716,226
Galit Lahav · Harvard Medical School · R35 · FY2023 · GM

Development of a Universal Influenza Vaccine Against Influenza A and B Viruses

$716,192
Harvinder Singh Gill · Texas Tech University · R01 · FY2019 · AI

ENHANCEMENT OF BIOMARKERS FOR TYPE 1 DIABETES

$716,158
Massimo T Pietropaolo · Baylor College Of Medicine · R01 · FY2018 · DK

Ultrasensitive detection of circulating DNA methylation for head and neck cancer prognosis

$716,123
Christine H Chung · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · DE

Characteristics and protective efficacy of human antibodies against M. tuberculosis

$716,093
Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2022 · AI

Characteristics and protective efficacy of human antibodies against M. tuberculosis

$716,093
Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2023 · AI

DNA Vaccines

$716,083
George N. Pavlakis · Basic Sciences · Z01 · FY2007 · CA

Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery

$716,070
Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2019 · AI

Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells

$715,781
Hongjun Wang · Medical University Of South Carolina · R01 · FY2019 · DK

Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia

$715,641
Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins

$715,640
Saar Gill · University Of Pennsylvania · R01 · FY2024 · NS

Investigating disseminated cancer cell clonal cooperation and immune control in dormancy and metastasis

$715,578
Julio A Aguirre-Ghiso · Albert Einstein College Of Medicine · U01 · FY2024 · CA

A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events

$715,543
Adam Mor · Columbia University Health Sciences · R01 · FY2025 · AI